6 insiders reported 10 Form 4 transactions for Drugs Made In America Acquisition II Corp. (DMII) over the past 18 months (most recent 2025-10-17). Recent activity: Do Catherine (Director) Buy 100,000 shares, Shulgan Myron W. (Director) Buy 100,000 shares, Prasad Sridhar G. (Director) Buy 100,000 shares, Drugs Made In America Acquisition II LLC (Insider) Buy 700,000 shares, Drugs Made In America Acquisition II LLC (Insider) Sell 400,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-17 | Do Catherine | Director | Buy | 100,000 | $0 |
| 2025-10-02 | Shulgan Myron W. | Director | Buy | 100,000 | $0 |
| 2025-10-01 | Prasad Sridhar G. | Director | Buy | 100,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | Insider | Buy | 700,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | Insider | Sell | 400,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | Insider | Sell | 8.0M | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | 700,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Sell | 400,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Sell | 8.0M | $0 |
| 2025-10-01 | Worman Glenn C. | CFO | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2025-10-17